This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
EU Compassionate Use Programme (CUP) Regulatory Framework and Points to Consider Before CUP Implementation

Published on: Apr 26, 2010
For some patients, compassionate use programmes (CUPs) are the only way to access promising medicinal products that are not yet authorized and for which clinical trials are either not available or in which these patients cannot participate.
Download the full resource now
Fill in the form to download the content